Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Anika Therapeutics (ANIK) Return on Equity: 2010-2024

Historic Return on Equity for Anika Therapeutics (ANIK) over the last 15 years, with Dec 2024 value amounting to -0.26%.

  • Anika Therapeutics' Return on Equity fell 7.00% to -0.13% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.13%, marking a year-over-year decrease of 7.00%. This contributed to the annual value of -0.26% for FY2024, which is 6.00% up from last year.
  • Latest data reveals that Anika Therapeutics reported Return on Equity of -0.26% as of FY2024, which was up 18.41% from -0.32% recorded in FY2023.
  • Anika Therapeutics' Return on Equity's 5-year high stood at 0.02% during FY2021, with a 5-year trough of -0.32% in FY2023.
  • Over the past 3 years, Anika Therapeutics' median Return on Equity value was -0.26% (recorded in 2024), while the average stood at -0.21%.
  • In the last 5 years, Anika Therapeutics' Return on Equity grew by 11bps in 2021 and then fell by 26bps in 2023.
  • Anika Therapeutics' Return on Equity (Yearly) stood at -0.09% in 2020, then increased by 11bps to 0.02% in 2021, then fell by 8bps to -0.06% in 2022, then fell by 26bps to -0.32% in 2023, then increased by 6bps to -0.26% in 2024.